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Gene Expression Proﬁles of Intracellular and Membrane Progesterone
Receptor Isoforms in the Mediobasal Hypothalamus During Pro-Oestrus
B. Liu and L. A. Arbogast
Department of Physiology, Southern Illinois University School of Medicine, Carbondale, IL, USA.
Progesterone is involved in biological functions in the uterus, ovary,
mammary gland and brain of various species (1). Many progester-
one effects are mediated by the classical intracellular progesterone
receptor (PR) isoforms. However, the recent identiﬁcation of mem-
brane progesterone receptors (mPR) provides another mechanism
for progesterone action. PR-expressing cells in the brain are found
in discrete brain regions, including the preoptic area, periventricular
nucleus, anterior hypothalamus, ventromedial nucleus, arcuate
nucleus and median eminence (2). The mediobasal hypothalamus
(MBH) contains important populations of PR-containing neuroendo-
crine neurones implicated in luteinising hormone (LH) and prolactin
release (3–7). The pre-ovulatory progesterone rise contributes to the
ampliﬁcation or extension of the LH and prolactin surges on pro-
oestrus in rats (8–11)
Two PR isoforms are derived from a single gene and generated
from alternative transcriptional and translational start sites (12–15).
The structural difference between the PRA and PRB isoforms is an
additional 164 amino acids located at the N-terminus of PRB. The
differential expression of PRA and PRB among target tissues (16,
17) contributes to the appropriate cell-speciﬁc responses and dis-
tinct physiological functions (18–20). Oestradiol and progesterone
have the capacity to regulate PR gene expression (2, 21–23). During
the oestrous cycle, PRB was found to be the predominant PR
isoform in the hypothalamus, preoptic area and frontal cortex and
differential PRA and PRB expression were observed in the hypothal-
amus, preoptic area and the frontal cortex (17).
The rapid nongenomic progesterone actions initiated at the cell
surface by binding to the membrane receptors have received
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Progesterone action is mediated by its binding to speciﬁc receptors. Two progesterone receptor
(PR) isoforms (PRA and PRB), three membrane progesterone receptor (mPR) subtypes (mPRa, mPRb
and mPRc) and at least one progesterone membrane-binding protein [PR membrane component 1
(PRmc1)] have been identiﬁed in reproductive tissues and brain of various species. In the present
study, we examined gene expression patterns for PR isoforms, mPR subtypes and PRmc1 in the rat
mediobasal hypothalamus (MBH) during pro-oestrus. The mRNA level for each receptor subtype
was quantiﬁed by a real-time reverse transcriptase-polymerase chain reaction (RT-PCR) at the time
points: 13.00 h on dioestrous day 2; 09.00, 13.00, 17.00 and 22.00 h on pro-oestrus; and 13.00 h
on oestrus. For PR, one primer set ampliﬁed PRA+PRB, whereas a second primer set ampliﬁed PRB.
As expected, PRA+PRB mRNA expression was greater than PRB in MBH tissue. PRB mRNA levels
increased throughout the day on pro-oestrus, with the highest levels being observed at 17.00 h.
PRB mRNA levels in the MBH were increased by 2.4- and 3.0-fold at 13.00 and 17.00 h, respec-
tively, on pro-oestrus compared to 13.00 h on dioestrous day 2. There were differential mRNA
expression levels for mPRs and PRmc1 in the MBH, with the highest expression for PRmc1 and the
lowest for mPRc. The mPRa mRNA contents at 13.00 and 17.00 h on pro-oestrus were increased
by 1.5-fold compared to that at 13.00 h on dioestrous day 2. The mPRb mRNA levels at 13.00 and
17.00 h on pro-oestrus were 2.5- and 2.4-fold higher compared to that at 13.00 h on dioestrous
day 2, respectively. PRA+PRB, mPRc and PRmc1 mRNA levels did not vary on pro-oestrus. These
ﬁndings suggest that the higher expression of PRB, mPRa and mPRb in the MBH on pro-oestrous
afternoon may inﬂuence both genomic and nongenomic mechanisms of progesterone action dur-
ing the critical pre-ovulatory period.
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nated mPRa, was cloned from spotted seatrout ovary and its protein
met the designation as a steroid membrane receptor (27). Subse-
quently, mPR subtypes, mPRa, mPRb and mPRc, were identiﬁed in
tissues including ovary, hypothalamus and pituitary gland (28–30).
The mPR protein has an approximately 40 kDa molecular mass and
seven transmembrane domains (28–30). In addition to the mPRs, a
small progesterone-binding protein (25 kDa) may also mediate
progesterone action (31). This progesterone-binding protein was
initially identiﬁed from porcine vascular smooth muscle cells and liver
microsomes (32, 33). This protein was referred to as PR membrane
component 1 (PRmc1) and has one single transmembrane domain
(34). PRmc1 was detected in the reproductive system (35, 36) and
basal forebrain (37).
The present study explored PRs, mPRs and PRmc1 gene expression
patterns in the MBH during oestrous cycle, especially on pro-oestrus.
The study provides important information for understanding
progesterone regulation of hypothalamic neuronal activities during
the critical pre-ovulatory phase of the reproductive cycle.
Materials and methods
Animals
Adult female Sprague–Dawley rats (200–250 g) were obtained from
Charles River (Raleigh, NC, USA). Rats were housed under a 14 : 10 h
light⁄dark cycle (lights on 07.00 h) and controlled temperature. Food and
water were supplied ad lib. The stage of the oestrous cycle was monitored
by performing a daily vaginal lavage at 10.00–12.00 h. Only rats exhibiting
three consecutive 4-day oestrous cycles were used in the study. Rats were
killed by decapitation at 13.00 h on dioestrus 2, 09.00, 13.00, 17.00 and
22.00 h on pro-oestrus, or 13.00 h on oestrus. The brain was removed
rapidly and frozen in Fisherbrand Super Friendly Freeze It solution (Fisher
Scientiﬁc, Pittsburgh, PA, USA) and stored at )80  C. MBH tissue was
punched with a 2-mm diameter sample corer (Fine Science Tools, Foster
City, CA, USA) from frozen brain equilibrated to )20  C. The coordinates
were )1.7 and )3.7 mm from Bregma and 1.0 mm laterally as determined
from optic chiasm and lateral hypothalamic sulci on the ventral surface
of the brain (38). The MBH core sample was placed under a dissecting
microscope and cut at 1.5 mm from the ventral surface of the brain. The
MBH fragment included the arcuate nucleus, periventricular nucleus, part
of ventromedial hypothalamus, as well as the median eminence. Dissected
MBH tissue was used for RNA isolation. All animal experiments were con-
ducted according to the National Institutes of Health Guide for the Care
and Use of Laboratory Animals. The Institutional Animal Care and Use
Committee at Southern Illinois University at Carbondale approved the
experimental protocols.
RNA isolation
Total RNA was isolated from the MBH tissue using RNA Bee method (Tel-Test
Inc., Friendswood, TX, USA) according to the manufacturer’s instructions.
Brieﬂy, MBH tissue was homogenised in samples in 0.8 ml RNA Bee solution
using a glass homogeniser. Chloroform (80 ll) was added for phase separation
and samples were centrifuged at 12 000 g (4  C) for 15 min. RNA in the aque-
ous phase was precipitated with 0.4 ml isopropanol. After centrifugation, RNA
precipitates were washed with 0.8 ml of 75% ethanol and RNA pellet was sol-
ubilised in water. RNA quantity was determined spectrophotometrically. RNA
samples were stored at )80  C until further use.
cDNA synthesis
Complementary DNA (cDNA) was synthesised using SuperScript
TM First-
strand synthesis system (Invitrogen, Carlsbad, CA, USA). A 12-ll reaction,
including 5 lg of RNA, 1 ll of oligo(dT)12–18 (25 lg⁄ll) and diethylpyrocar-
bonate-treated water was incubated at 70  C for 10 min, followed by at
least 1 min of incubation on ice. The cDNA synthesis mix, including 2 llo f
(10·) reverse transcriptase buffer, 2 llo f2 5m M magnesium chloride, 1 ll
of 10 mM deoxynucleotide triphosphates and 2 ll of 0.1 mM dithiothreitol,
was added to the above reaction tube. The reaction mixture was then incu-
bated at 42  C for 5 min. After addition of 1 ll (200 units) SuperScript
TM
III reverse transcriptase, the reaction mixture was incubated at 42  C for
50 min. The reaction was terminated by incubation at 70  C for 15 min.
RNAase H (1 ll) was added to each tube and the reaction mixture was
incubated at 37  C for 20 min. The cDNA samples were stored at )20  C.
Real-time polymerase chain (PCR) for PRs, mPRs and
PRmc1
Real-time PCR was performed in the SmartCycler System (Cepheid, Sunnyvale,
CA, USA) by utilising the SYBR  Green JumpStart
TM Taq ReadyMix
TM Kit (S
4438; Sigma, St Louis, MO, USA). The 25-ll reactions contained 12.5 llo f
SYBR Green JumpStart Taq ReadyMix, 0.5 ll of each primer (0.2 lM ﬁnal con-
centration), 1 ll of cDNA template and 10.5 ll of water. Primer sequences
were designed using MacVector 9.5 software (MacVector Inc., Cary, NC, USA)
and are presented in Table 1. After the initial denaturation step at 95  C for
2 min, ampliﬁcation was performed for 40 cycles of denaturation at 95  C for
15 s, annealing at 60  C for 30 s, and elongation at 72  C for 30 s. The speci-
ﬁcity and purity of the ampliﬁcation reaction was determined by performing a
melting curve analysis at 60  Cu pt o9 5 C at 0.5  C increments. One distinct
peak was observed, indicating that a single DNA sequence was ampliﬁed dur-
ing PCR. In addition, end reaction products were visualised on ethidium bro-
mide-stained 2% agarose gels and the appearance of a sole band of the
correct molecular size was conﬁrmed. Each PCR assay included two negative
controls, without reverse transcription or without template in the PCR reac-
tion. The data were analysed with SmartCycler Software. The comparative
threshold cycle number (Ct) method (2
)DDCt) was used to quantify the results
obtained by real-time RT-PCR (39). The gene expression patterns of PRA+PRB,
PRB, mPRa, mPRb, mPRc and PRmc1 were normalised to that of glyceralde-
hyde 3-phosphate dehydrogenase (GAPDH). GAPDH mRNA levels did not
change during the oestrous cycle in the MBH as determined from the mean
Ct value for each group. The DCt in each sample was calculated by subtracting
Ct
GAPDH from Ct
PRs, mPRs or PRmc1. The gene expression changes were deter-
mined by subtracting DCt experimental groups (pro-oestrus and oestrus) from
the DCT control group (13.00 h dioestrus 2). Fold induction was determined by
calculating 2
)DDCt. The real-time PCR efﬁciency for each primer pair was cal-
culated using the equation E = 10
)[1 ⁄ s] (40), where ‘s’ is the slope derived
from the SmartCycler REST-MCS software.
Statistical analysis
Data are presented as the mean  SEM. Statistical signiﬁcance was evalu-
ated by one-way ANOVA and multiple comparisons were made with Fisher’s
least signiﬁcant procedures. P < 0.05 was considered statistically signiﬁcant.
Results
Standard curves for PRs, mPRs, PRmc1 and GAPDH cDNA
To establish standard curves for PRs, mPRs, PRmc1 and GAPDH
gene expression in the MBH, we tested cDNA concentrations of 0.5,
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which included MBH tissues from dioestrus 2, pro-oestrus and oes-
trus. This study was repeated three times with different mixed
cDNA samples. As shown in Fig. 1, a concentration-dependent
change of Ct value was observed for PRA+PRB, PRB, mPRa, mPRb,
mPRc, PRmc1 and GAPDH in MBH cDNA samples. The real-time
PCR efﬁciencies of the primer sets for GAPDH, PRA+PRB, PRB,
mPRa, mPRb, mPRc and PRmc1 were 1.89, 1.95, 1.93, 1.85, 1.81,
1.94 and 1.87, respectively. GAPDH, the housekeeping gene, and
PRmc1 mRNA levels in the MBH were expressed at the highest lev-
els compared to PRs and mPRs mRNA levels. As expected, because
PRA+PRB primer set recognises a cDNA sequence common to both
PRA and PRB, the expression of PRA+PRB was higher than PRB
alone. The mRNA expression levels for mPRa and mPRb were
higher in MBH than mPRc mRNA levels (Fig. 1).
Expression of PR genes in the MBH
Gene expression patterns for PRA+PRB and PRB in the MBH were
evaluated at 13.00 h on dioestrus 2; 09.00 13.00, 17.00 and
22.00 h on pro-oestrus; and 13.00 h on oestrus. PRA+PRB mRNA
contents in the MBH were similar on dioestrus 2, pro-oestrus and
oestrus (Fig. 2A). By contrast, PRB mRNA contents were increased
1.5-, 2.4- and 3.0-fold at 09.00, 13.00 and 17.00 h, respectively, on
pro-oestrus, compared to 13.00 h on dioestrus 2. PRB mRNA con-
tent at 22.00 h on pro-oestrus declined to 2.0-fold dioestrous
levels, and was further reduced by 13.00 h on oestrus to 43% of
dioestrous levels (F5,39 = 4.202, P < 0.01; Fig. 2B).
Expression of mPR genes in the MBH
Gene expression of mPRs, including mPRa, mPRb, mPRc and
PRmc1, in the MBH were also determined at 13.00 h on dioestrus
2; 09.00, 13.00, 17.00 and 22.00 h on pro-oestrus; and 13.00 h on
oestrus. Analysis using one-way ANOVA revealed signiﬁcant changes
in mRNA contents for mPRa (F5,38 = 2.494, P < 0.05; Fig. 3A) and
mPRb (F5,39 = 2.884, P < 0.05; Fig. 3B) in the MBH, but no changes
were found for mPRc (Fig. 3C) and PRmc1 (Fig. 3D) expression. Spe-
ciﬁcally, mPRa mRNA contents at 13.00 and 17.00 h on pro-oestrus
were signiﬁcantly higher than that at 13.00 h on dioestrus 2,
Table 1. Primer Sequences for Quantitative Real-time Polymerase Chain Reaction.
Gene name GenBank accession no. Primer sequence Amplicon size (bp)
PRA+PRB NM_022847 Forward: GGT CTA AGT CTC TGC CAG GTT TCC 182
Reverse: CAA CTC CTT CAT CCT CTG CTC ATT C
PRB NM_022847 Forward: GCA TCG TCT GTA GTC TCG CCA ATA C 176
Reverse: GCT CTG GGA TTT CTG CTT CTT CG
PRa NM_001034081 Forward: CAC ACT GTT CCA GCA GCA CAA C 143
Reverse: CAA TGA TGA AGA GGG GCA GAG C
PRb NM_001014099 Forward: CTC TTT CAG AAG CAC AAC GAG GTG 168
Reverse: GGT GAG GTA AGT GAT TGA CGA CAG G
PRc NM_001014092 Forward: CTC CTG GAC GCT TTG ACT ACA TTG 198
Reverse: TGC TGA GGC TGA AGA TGA TGC
PRmc1 NM_021766 Forward: ACT TCA CCC CTG CCG AAC TAA G 199
Reverse: TCA TCC TTC AGT GCT TCT TTG TCC
GAPDH DQ403053 Forward: AAC GAC CCC TTC ATT GAC C 191
Reverse: TCC ACG ACA TAC TCA GCA C
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Fig. 1. Standard curves for real-time polymerase chain reaction ampliﬁca-
tion of progesterone receptors (PRs), membrane progesterone receptors
(mPRs) and PR membrane component 1 (PRmc1) in the mediobasal hypo-
thalamus (MBH) tissue of rats. The lower Ct value represents higher mRNA
concentrations of certain target genes in the tissue. As indicated on the ﬁg-
ure, glyceraldehyde 3-phosphate dehydrogenase has the highest mRNA level
in the MBH, followed in expression level order by PRmc1, PRa, PRA+PRB,
PRb, PRB, PRc.
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increase at 13.00 and 17.00 h on pro-oestrus compared to that at
13.00 h on dioestrus 2. The mRNA contents for mPRb at 13.00 and
17.00 h on pro-oestrus were higher than the values at all the other
time points during the oestrous cycle. The mPRb mRNA contents at
13.00 and 17.00 h were 2.5- and 2.4-fold higher than that at
13.00 h on dioestrus 2, respectively. PRmc1 and mPRc mRNA levels
were not altered on pro-oestrus.
Discussion
The present study characterised gene expression patterns of PR iso-
forms (PRA+PRB and PRB), three mPR subtypes (mPRa, mPRb and
mPRc) and PRmc1 in the rat MBH during the oestrous cycle, espe-
cially on pro-oestrus. The data obtained indicate that PRA, PRB,
mPRa, mPRb, mPRc and PRmc1 are expressed in MBH tissue, albeit
at different levels. PRB, mPRa and mPRb expression in the MBH
varied during the oestrous cycle with higher mRNA contents on
pro-oestrous afternoon compared to that on pro-oestrous morning,
early afternoon of dioestrus 2 and early afternoon of oestrus. This
basic proﬁle for PRs gene expression in the MBH during the repro-
ductive cycle may be beneﬁcial for understanding the mechanism(s)
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Fig. 2. PRA+PRB (A) and PRB (B) gene expression patterns in the medioba-
sal hypothalamus of cycling female rats. Rats were killed at 13.00 h on
dioestrus 2; 09.00, 13.00, 17.00 and 22.00 h on pro-oestrus; or 13.00 h on
oestrus. Each value represents the mean  SEM of determinations from
seven to ten rats. *P < 0.05, **P < 0.01, ***P < 0.001 compared to the corre-
sponding group indicated by a long vertical line.
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Fig. 3. Gene expression patterns for mPRa (A), mPRb (B), mPRc (C) and
PRmc1 (D) in the mediobasal hypothalamus of cycling female rats. Rats were
killed at 13.00 h on dioestrus 2; 09.00, 13.00, 17.00 and 22.00 h on pro-
oestrus; or 13.00 h on oestrus. Each values represents the mean  SEM of
determinations from seven to ten rats. *P < 0.05, **P < 0.01 compared to
the corresponding group indicated by a long vertical line.
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and reproductive behaviours.
Of the classical intracellular PRs, PRB mRNA contents in the
MBH ﬂuctuated during the oestrous cycle, especially on pro-oes-
trus. The highest level of PRB mRNA expression occurred during
pro-oestrous afternoon, but PRB mRNA contents declined on pro-
oestrous evening and were markedly reduced by oestrous after-
noon. These data are in general agreement with the previous study
by Guerra-Araiza et al. (17) with respect to differential mRNA
expression of PR isoforms during the oestrous cycle. These investi-
gators examined PRB expression at 12.00 h on each day of the
oestrous cycle and reported highest PRB mRNA levels in the hypo-
thalamus on pro-oestrus compared to other days of the oestrous
cycle. Our data expand these data to indicate that PRB expression
continues to increase during pro-oestrous afternoon and reaches
the highest levels coincident with the timing of LH and prolactin
surges. It is not clear how these changes in PRB mRNA translate to
functional PRB protein on pro-oestrous afternoon. Guerra-Araiza
et al. (41) reported no change in PRB isoforms protein content in
the hypothalamus at 12.00 h on pro-oestrus compared to 12.00 h
on other days of the oestrous cycle. However, future studies should
examine protein expression for PR and mPR isoforms throughout
pro-oestrous day because elevated levels in the later afternoon
might provide maximum sensitivity at the time of the pre-ovulatory
progesterone rise. Early studies indicated that PR binding in the
hypothalamus is highest on pro-oestrus and lowest on dioestrus
(42). Because the entire PRA sequence is contained within the PRB
sequence, primers were designed to amplify PRA+PRB. It is note-
worthy that PRA+PRB mRNA contents were not signiﬁcantly altered
during pro-oestrous day or on different days of the oestrous cycle.
These data suggest that PRA isoforms expression did not increase
in a similar manner to PRB on pro-oestrus or potentially offset PRB
expression changes. In either case, the data obtained in the present
study suggest that the ratio of PRA : PRB might be altered during
pro-oestrus and allow for distinct progesterone-dependent tran-
scriptional changes in the MBH during the pre-ovulatory period.
The data obtained in the present study indicate that PRB may be
more sensitive to endogenous steroid hormone variance. A number
of studies reported that PR expression in the hypothalamus is
dependent on prior oestradiol priming (2, 21, 22, 43). Oestradiol
treatment of ovariectomised rats results in increased PR expression
(22, 43, 44) and a high co-expression of PR with tyrosine hydroxy-
lase (TH) in the arcuate nucleus (3, 4, 45). Oestrogen receptor-a pri-
marily mediates oestradiol-mediated PR expression in speciﬁc
hypothalamic nuclei, but other oestradiol receptor(s) or splice vari-
ant(s) may also contribute in some nuclei (46, 47). The action of
oestradiol with respect to promoting PR expression was observed at
24 h post-injection in the arcuate and ventromedial nuclei of rat
hypothalamus (22). In addition, a higher PRB mRNA content, as
compared to PRA+PRB mRNA contents, was obtained in the hypo-
thalamus⁄preoptic area within 12 h after oestradiol treatment (43).
These data taken together with our data suggest that increased
PRB expression on pro-oestrus afternoon may be a result of the
high serum oestradiol that rises from late on dioestrus 2 (48) and
is maintained until 19.00 h on pro-oestrus (49). Indeed, oestradiol
enhances PRB gene expression in the preoptic area and hypothala-
mus (23, 43, 50). Two functionally distinct promoters have been
identiﬁed in the rat PR gene with a degree of promoter speciﬁcity
for oestrogen responsiveness (12, 14). These characteristics of the
rat PR promoter may account for the ability of oestradiol to prefer-
entially induce PRB expression in the MBH. By contrast to the
action of oestrogen, progesterone inhibits PR gene expression in
the hypothalamus (23). The pre-ovulatory progesterone rise that
occurs from 17.00 h through 22.00 h (49) may contribute to the
reduction of PRB mRNA levels in the MBH at 22.00 h on pro-oes-
trus. At 3 h after treatment, progesterone diminishes the protein
content of PR isoforms in the hypothalamus of oestradiol-primed
ovariectomised rats (41).
This is the ﬁrst study to describe the gene expression patterns
of mPRs and PRmc1 in the MBH. Our data show that mPRa and
mPRb gene expressions varied on pro-oestrous afternoon. The
mPRa and mPRb mRNA levels were higher at 13.00 and 17.00 h
on pro-oestrus than at other time points tested during the
oestrous cycle. Interestingly, the pro-oestrous changes in mPRa
and mPRb expression levels were similar to that of PRB and the
proﬁle of the changes is consistent with up-regulation by oestra-
diol and subsequent down-regulation by progesterone. Indeed,
oestradiol increases mPRa and mPRb mRNA expression in human
myometrium, albeit with dissimilar timing and magnitude, whereas
progesterone differentially modulates expression of these receptors
(51). The identiﬁcation and characterisation of mPRs is a recent
development in our understanding of rapid progesterone signal-
ling. The mPRs have characteristics of seven transmembrane cell
surface receptors. Recently, mPR was demonstrated to directly
couple to Gi protein to down-regulate membrane-bound adenylyl
cyclase activity (52). Moreover, mPRa and mPRb protein are found
in the plasma membrane fraction of GT1-7 cells (53). Activity
changes of protein kinase C and calcium and calmodulin-depen-
dent protein kinase II in the ventromedial nucleus and preoptic
area of the rat hypothalamus can be initiated by progesterone
(54, 55). These studies imply that mPR-regulated intracellular sig-
nalling pathways may be sites for progesterone action in the
MBH. Further studies are required before we fully understand the
subcellular localisation, importance and regulation mPRa and
mPRb in the MBH during the reproductive cycle. Although there
was a high expression of PRmc1 mRNA and a relatively low level
of mPRc mRNA in the MBH, their mRNA levels were not altered
at the times examined during the rat oestrous cycle. However,
PRmc1 expression in the ventromedial nucleus of the rat hypo-
thalamus is up-regulated by oestradiol and down-regulated by
progesterone (37). The MBH fragment in the present study
included the arcuate nucleus as well as the ventromedial nucleus
and the modest, albeit nonsigniﬁcant, changes in PRmc1 during
pro-oestrus in the present study may represent a contribution
from the ventromedial nucleus.
The data obtained in the present study indicate progressively
increasing expression levels for PRB, mPRa and mPRb throughout
pro-oestrous afternoon. Peak expression occurs at the time of the
onset of the pre-ovulatory rise in circulating progesterone levels
and suggests that increased progesterone responsiveness might be
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tors. It is notable that oestradiol also increases 3b-hydroxy-steroid
hydrogenase⁄D5-D4 isomerase in the hypothalamus⁄preoptic area
of ovariectomised-adrenaleised rats and stimulates de novo proges-
terone synthesis in hypothalamic astrocyte cultures (43, 56, 57).
The ovarian steroid hormones, oestradiol and progesterone, are
essential for the expression and ampliﬁcation⁄extension of LH and
prolactin surges on pro-oestrus. The intracellular PRs are critically
involved in LH surge in rats, which is blocked or attenuated by
the intracellular PR antagonist, RU486 (50, 51). Blockade of local
progesterone synthesis in the brain also results in decreased LH
surge (57). The LH surge is absent in PR knockout mice on pro-
oestrous day and in ovariectomised PR-knockout mice treated with
steroid hormones (58). Recently, mPRs have been implicated in the
PRA⁄PRB-independent rapid negative-feedback mechanisms respon-
sible for the suppression of GnRH release (53). Given the timing of
increases in mPRa and mPRb expression just prior to the onset of
the LH surge, our data point to the importance of examining the
role of the mPRs in positive feedback-mechanisms responsible for
LH secretion on pro-oestrus in future studies.
Our laboratory has an interest in understanding the regulation of
the pre-ovulatory prolactin surge. Although the prolactin surge is
absolutely dependent on oestradiol (48), progesterone is responsible
for amplifying the magnitude or extending the duration of the
surge by decreasing TH activity and TH phosphorylation state in
tuberoinfundibular dopamine (TIDA) neurones of MBH (8, 9, 49).
The progesterone-induced decrease in TIDA neuronal activity can be
blocked by antisense oligonucleotides to progesterone receptor (59),
suggesting that progesterone is acting via speciﬁc PR. The high
co-expression of PR with TH in the MBH supports that the neuro-
endocrine dopaminergic neurones in the arcuate nucleus are the
targets of progesterone action (3–5, 45, 60, 61). Noteworthy, the
MBH tissue dissected in the present study included arcuate nucleus
and median eminence, where dopaminergic neuronal body or termi-
nals are located. Additionally, the colocalisation of PR neuropeptide
Y (5), neurotensin (6) and dynorphin (62) in the arcuate nucleus
indicates the potential importance of this study in a wide range of
physiological functions.
Differential expression patterns for PRs and mPRs during
oestrous cycle, especially on pro-oestrus, provide an important
proﬁle for understanding progesterone-mediated activity in the
MBH. Whether these changes in PR and mPR mRNA levels trans-
late into differences in functional protein levels for PR and mPR
isoforms in the MBH remains to be explored in future studies.
The present study suggests that increased expression of PRB,
mPRa and mPRb may enhance progesterone responsiveness in
the MBH on pro-oestrous afternoon and contribute to genomic
and⁄or nongenomic mechanisms underlying the progesterone
action with respect to regulating pituitary hormone secretion or
other reproductive processes occurring during the pre-ovulatory
period.
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